CinCor Pharma, Inc., (CINC) Social Stream
CINCOR PHARMA INC (CINC) Price Targets From Analysts
Use the tables below to see what analysts covering CINCOR PHARMA INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-24 | 4 | $30 | $27 | $29 | $29.06 | -0.21% |
| 2022-07-21 | 4 | $35 | $30 | $32 | $29.06 | 10.12% |
| 2022-08-15 | 4 | $60 | $45 | $51.666 | $29.06 | 77.79% |
| 2022-09-07 | 5 | $73 | $45 | $57 | $29.06 | 96.15% |
| 2022-09-19 | 5 | $73 | $50 | $60.75 | $29.06 | 109.05% |
| 2022-10-19 | 6 | $73 | $50 | $61.4 | $29.06 | 111.29% |
| 2022-11-08 | 7 | $73 | $50 | $62.333 | $29.06 | 114.5% |
| 2022-11-29 | 7 | $67 | $22 | $48.8 | $29.06 | 67.93% |
| 2022-12-08 | 8 | $67 | $22 | $44.333 | $29.06 | 52.56% |
| 2023-01-10 | 7 | $67 | $22 | $45.666 | $29.06 | 57.14% |
| 2023-01-12 | 7 | $67 | $30 | $47.166 | $29.06 | 62.31% |
| NA | 4 | $NA | $NA | $NA | $29.06 | NA% |
The Trend in the Analyst Price Target
CINC's average price target has moved down $15.17 over the prior 65 days.
CINC reports an average of 91.09% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-15 | 4 | 60 | 45 | 51.666 | 35.94 | 43.76% |
| 2022-08-22 | 5 | 73 | 45 | 57.000 | 34.92 | 63.23% |
| 2022-09-19 | 5 | 73 | 50 | 60.750 | 27.58 | 120.27% |
| 2023-01-09 | 7 | 67 | 22 | 45.666 | 28.74 | 58.89% |
| 2023-01-12 | 6 | 67 | 30 | 47.166 | 29.07 | 62.25% |
CINC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.57 | 5 | 0 | 2 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
CINC's average broker recommendation rating worsened by 0.32 over the prior 48 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CINC as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, CINCOR PHARMA INC's upside potential (average analyst target price relative to current price) is greater than 978.28% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, CINCOR PHARMA INC's average analyst price target is greater than 1328.56% of them.
- In the context of Pharmaceutical Products stocks, CINCOR PHARMA INC's variance in analysts' estimates is lower than -420.24% of them.
- CINC has a greater number of analysts covering the stock than 1085.56% of stocks in the small market cap category.
In the Pharmaceutical Products industry, BWV, ANTX, and THRD are the three stocks most similar to CINCOR PHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is CINC a Buy, Hold or Sell? See the POWR Ratings now!